Cost-effectiveness of an adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease.
Freddy CalderaAaron C SpauldingBijan BorahJim MoriartyYe ZhuMary S HayneyFrancis A FarrayePublished in: Alimentary pharmacology & therapeutics (2023)
In our model, vaccination with RZV was cost-effective for all adult patients with IBD.
Keyphrases